[Federal Register Volume 80, Number 56 (Tuesday, March 24, 2015)]
[Notices]
[Pages 15617-15618]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-06651]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Economic Studies of 
Immunization Policies and Practices, Funding Opportunity Announcement 
(FOA) IP15-001 and US Platform to Measure Influenza Vaccine

[[Page 15618]]

Effectiveness against Laboratory-Confirmed Influenza-Associated 
Hospitalizations, FOA IP15-002, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Time And Date: 10:00 a.m.-4:00 p.m., April 15, 2015 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters For Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Economic Studies of Immunization Policies and Practices'', FOA 
IP15-001 and ``US Platform to Measure Influenza Vaccine Effectiveness 
against Laboratory-confirmed Influenza-associated Hospitalizations'', 
FOA IP15-002.
    Contact Person For More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop 
E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-06651 Filed 3-23-15; 8:45 am]
BILLING CODE 4163-18-P